Business
Organigram is a Canadian company that produces and sells cannabis and cannabis-derived products, including dried flower, pre-rolls, vapes, concentrates, oils, and edibles, for both the adult-use and medical markets. The company generates revenue through sales to provincial cannabis boards, direct sales to medical patients, and exports and partnerships in certain international markets. ==History==
History
On March 24th, 2025, Organigram investors approved rebranding from Organigram Holdings to Organigram Global. In 2023, the company reported a quarterly profit of $5.3 million, reversing a $1.3 million loss a year earlier, as revenue rose to $43.3 million from $30.4 million and margins improved. ==See also==